Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C
Abstract
Summary: HCV is the leading cause of cirrhosis and liver cancer in the U.S . The C enter for D isease C ontrol ( CDC ) has recently recommended ‘ B irth C ohort S creening’ of the U.S . Adult population to reduce the future burden of undiagnosed HCV infections in the U.S . Our aim was to assess independent predictors of receiving treatment in a cohort of HCV ‐infected patients. The H epatitis C follow‐up questionnaires of the N ational H ealth and N utrition E xamination S urveys ( NHANES ) conducted from 2001 to 2010 were used. The NHANES participants who tested positive for HCV RNA were followed by CDC 6 months after initial testing with questions related to their awareness of their infection and history or intention to receive treatment. A total of 500 NHANES participants tested positive for HCV RNA and were targeted for follow‐up. Of these, only 203 had completed the follow‐up questionnaire (response rate of 40.6%). Of these, only 101 (50%) knew about their HCV positivity before NHANES , and from them, only 34 (17%) had received treatment. In multivariate analysis, prior knowledge about their HCV infection in HCV ‐positive individuals was independently associated with receiving routine care from a doctor or HMO , with higher income, female gender, being in poor or fair health and not consuming excessive amounts of alcohol. On the other hand, the knowledge about HCV infection was the only independent predictor of receiving anti‐ HCV treatment (odds ratio 6.14). Knowledge about having HCV infection is the only independent predictor of receiving treatment. Therefore, birth cohort screening of the U.S . General population could lead to wider identification of HCV and potentially better management of the future burden of HCV and its complications.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The survey was limited by nonresponse bias, although the response rate is similar to those of similar mailed efforts.
“our survey was limited by nonresponse bias, although our response rate is similar to those of similar mailed efforts.”
From Depression and anxiety are common among patients with cirrhosis (2022) · cites this paper as [36]
Cites
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Poordad, F. F., McCone, J., Bacon, B. R., Bruno, S., Manns, M. P., Sulkowski, M., Jacobson, I. M., Reddy, K. R., Goodman, Z. D., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010494 · Cited by 2,512 · see citing works
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Jacobson, I. M., McHutchison, J. G., Dusheiko, G. M., Bisceglie, A. M. D., Reddy, K. R., Bzowej, N. H., Marcellin, P., Muir, A. J., Ferenci, P., Flisiak, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012912 · Cited by 2,394 · see citing works
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., Poordad, F. F., Goodman, Z. D., Sings, H. L., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009482 · Cited by 1,620 · see citing works
Telaprevir for Retreatment of HCV Infection
Zeuzem, S., Andreoné, P., Pol, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013086 · Cited by 1,549 · see citing works
Davis, G. L., Alter, M. J., El‐Serag, H. B., Poynard, T., & Jennings, L. W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 879 · see citing works
Chung, R. T., Andersen, J., Volberding, P. A., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032653 · Cited by 871 · see citing works
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Sherman, K. E., Flamm, S. L., Afdhal, N. H., Nelson, D. R., Sulkowski, M., Everson, G. T., Fried, M. W., Adler, M., Reesink, H. W., Martin, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014463 · Cited by 748 · see citing works
Denniston, M. M., Klevens, M. R., McQuillan, G. M., et al. (2011) · Hepatology · doi:10.1002/hep.25556 · Cited by 382 · see citing works
Rein, D. B., Smith, B. D., Wittenborn, J. S., Lesesne, S. B., Wagner, L. D., Roblin, D. W., Patel, N., Ward, J. W., & Weinbaum, C. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-4-201202210-00378 · Cited by 302 · see citing works
Depression screening: a practical strategy.
Nease, D. E., & Maloin, J. M. (2003) · PubMed · Cited by 177 · see citing works
The effects of HCV infection and management on health-related quality of life
Younossi, Z. M., Kallman, J. B., & Kincaid, J. (2007) · Hepatology · doi:10.1002/hep.21565 · Cited by 173 · see citing works
Self-citationDirect Economic Burden of Chronic Hepatitis C Virus in a United States Managed Care Population
Davis, K. L., Mitra, D., Medjedovic, J., Beam, C., & Rustgi, V. K. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e12c09 · Cited by 140 · see citing works
Zeuzem, S., Asselah, T., Angus, P., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.051 · Cited by 135 · see citing works
Economic model of a birth cohort screening program for hepatitis C virus
McGarry, L. J., Pawar, V. S., Panchmatia, H. R., et al. (2011) · Hepatology · doi:10.1002/hep.25510 · Cited by 111 · see citing works
Chronic hepatitis C: an age wave of disease burden.
McHutchison, J. G., & Bacon, B. R. (2005) · PubMed · Cited by 108 · see citing works
Leigh, J., Bowlus, C. L., Leistikow, B. N., et al. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.18.2231 · Cited by 106 · see citing works
The Changing Epidemiology and Natural History of Hepatitis C Virus Infection
Bialek, S. R., & Terrault, N. A. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.003 · Cited by 104 · see citing works
Stepanova, M., Kanwal, F., El‐Serag, H. B., et al. (2010) · Hepatology · doi:10.1002/hep.24131 · Cited by 90 · see citing works
Self-citationLalezari, J. P., Lawitz, E., Rodriguez‐Torres, M., et al. (2011) · Journal of Hepatology · doi:10.1016/s0168-8278(11)60063-9 · Cited by 46 · see citing works
Update on viral hepatitis: 2006
Tan, J. Y.-L., & Lok, A. S.-F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328049ddc1 · Cited by 34 · see citing works
An Overview of Emerging Therapies for the Treatment of Chronic Hepatitis C
Ilyas, J. A., & Vierling, J. M. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.05.002 · Cited by 32 · see citing works
Boceprevir for Chronic HCV Genotype 1 Infection
Limaye, A. R., Draganov, P. V., & Cabrera, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1105515 · Cited by 26 · see citing works
Long-Term Improvement in Health-Related Quality of Life After Orthotopic Liver Transplantation
Dan, A. A., & Younossi, Z. M. (2008) · Liver Transplantation · doi:10.1002/lt.21551 · Cited by 11 · see citing works
Self-citation1990–2010: Two Decades of Interferon-Based Therapy
Buti, M., & Esteban, R. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.05.007 · Cited by 10 · see citing works
Interferon-Free Regimens: The Near Future, the Likely and the Not So Likely
Shiffman, M. L. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.05.004 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Depression and anxiety are common among patients with cirrhosis
Hernaez, R., Kramer, J. R., Khan, A., Phillips, J., McCallister, K., Chaffin, K., Hernandez, A. P., Fullington, H., Ortiz, C., Blackwell, J.-M., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.045 · Cited by 77 · see citing works
- Authors
- Younossi, Z. M., Stepanova, M., Afendy, M., Lam, B. P., & Mishra, A.
- Affiliations
- Inova Health System (US)
- Inova Fairfax Hospital (US)
- Corresponding author
- Younossi, Z. M.
- Venue
- Journal of Viral Hepatitis
- Publisher
- Wiley
- Published
- 2013-03-25
- Volume
- 20
- Issue
- 8
- Pages
- 550-555
- ISSN
- 1352-0504 (ISSN-L)
- 1365-2893
- OpenAlex
- W2120263188
- Cited by
- 42
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2021: 1 · 2020: 1 · 2019: 4 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 11 · 2013: 2
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Viral Hepatitis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Keywords
- chronic hepatitis C, HCV treatment uptake, predictors of treatment, birth cohort screening, HCV RNA, NHANES, health care utilization, socioeconomic factors, alcohol consumption
- MeSH terms
- Adult, Aged, Female, Humans, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Patient Acceptance of Health Care, Surveys and Questionnaires, United States, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review